Both in Blank Checks
Drugs Made In America Acquisition vs Oaktree Acquisition Corp. III Life Sciences
Over the past year DMAA returned +5.6% and OACC returned +2.5%; their daily moves had a correlation of -0.05.
DMAA +5.6% OACC +2.5%Growth of $1, one year, split-adjusted
| Metric | DMAA | OACC |
|---|---|---|
| Price | $10.88 | $10.78 |
| Market cap | $264.1M | $265.0M |
| Today | 0.00% | 0.00% |
| 1 month | +1.2% | +0.4% |
| 6 months | +3.8% | +1.9% |
| Year to date | +4.9% | +1.9% |
| 1 year | — | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | -$329.7K | — |
| Dividend yield | — | — |
| Volatility (60d) | 1.8% | 4.7% |
| Short % of float | 0.4% | 0.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).